Project Details
| Status | Active |
|---|---|
| Effective start/end date | 6/27/19 → 6/26/29 |
Phase III Study of Daratumumab/rHuPH20 (NSC- 810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients with Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC
- Ganguly, Siddhartha (PI)
Project: Non Profit